Bioavailability of drugs with long elimination half-lives
- 1 January 1983
- journal article
- research article
- Published by Springer Nature in European Journal of Clinical Pharmacology
- Vol. 25 (5) , 689-693
- https://doi.org/10.1007/bf00542360
Abstract
Methods for estimating the bioavailability of drugs with long elimination half-lives are examined. Provided both absorption and disposition are linear a simple linear regression method is developed which can be used to calculate bioavailability in situations where only an incomplete estimate of the area under the curve (AUC) is available. The regression method and the traditional method of comparing the AUC following an oral dose to the AUC following an i.v. dose were applied to simulated data. It was found that the AUC ratio method works well as long as absorption is complete within the time over which the AUC is computed. The regression method is less precise than the AUC ratio method but is more accurate for drugs with long absorption half-lives. When applied to published data on a beta blocker the two methods produced comparable results. The bioavailability of amiodarone in three human subjects was calculated to be 0.20, 0.44 and 0.98 using the regression method with similar results from the ratio method. It is not possible to estimate the clearance of amiodarone from single dose data.This publication has 5 references indexed in Scilit:
- Amiodarone kinetics after oral dosesClinical Pharmacology & Therapeutics, 1982
- Pharmacokinetics of Amiodarone in RatsJournal of Cardiovascular Pharmacology, 1982
- Pharmacokinetics of Amiodarone in ManJournal of Cardiovascular Pharmacology, 1982
- Pharmacokinetics of amiodarone after intravenous and oral administrationEuropean Journal of Clinical Pharmacology, 1981
- Assessment of rate and extent of drug absorptionPharmacology & Therapeutics, 1981